From angiotensin receptor-neprilysin inhibitor exposure to a pragmatic pharmacist-led deprescribing intervention, & validating measures between the electronic health record and Medicare Claims, geriatrics research is shaping the future of care
- From angiotensin receptor-neprilysin inhibitor exposure to a pragmatic pharmacist-led deprescribing intervention, & validating measures between the electronic health record and Medicare Claims #geriatrics research is shaping the future of care for all of us as we age. Don’t miss this year’s Plenary Paper session at #AGS26. https://bit.ly/3PtWRuS
New York (March 25, 2026) – Researchers presenting at the American Geriatrics Society (AGS) Virtual Annual Scientific Meeting (#AGS26), taking place April 30th – May 2nd (pre-conference days Monday, April 27th – Wednesday, April 29th), represent the leading voices in geriatrics scholarship. Selected from a highly competitive pool of 746 submissions, this year’s Plenary Paper Presenters will showcase innovative research aimed at advancing the health and well-being of older adults. The #AGS26 Plenary Paper Session (Thursday, April 30th, 11:15–12:00 PM EST) will feature distinguished speakers that will highlight the wide-ranging impact of geriatrics research, demonstrating its critical role in shaping the future of caring for all of us as we age.
Sacubitril/Valsartan Use across Transitions between Community, Hospital, and Skilled Nursing Facility Settings (presented by Andrew R. Zullo, PharmD, PhD)